NCT03178825View on ClinicalTrials.gov

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

February 25, 2020

Study Completion Date

February 25, 2020

Conditions
Vaginal AtrophySexual DysfunctionDyspareuniaVaginal DrynessChronic UTI
Interventions
DEVICE

Hybrid Fractional Laser

Consecutive and coincident fractional 2940 nm and 1470 nm lasers

Trial Locations (6)

23235

The Female Pelvic Medicine Institute of Virginia, North Chesterfield

28207

Carolinas Healthcare System, Charlotte

32514

Coyle Institute, Pensacola

70112

Louisiana State University, New Orleans

77384

Woodlands Gynecology & Aesthetics, The Woodlands

95032

Women's Pelvic Health Institute, Los Gatos

All Listed Sponsors
lead

Sciton

INDUSTRY

NCT03178825 - Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter